It contains the active ingredient semaglutide, which works by mimicking the effects of a hormone in the body called glucagon-like peptide-1 (GLP-1)
Now, its time to consider discontinuing the medication, but its crucial to understand that maintaining your weight loss requires a commitment to ongoing healthy eating habits and regular exercise
Wegovy 7.2 mg has been the licensed top dose since 12th January 2026, when the MHRA approved the higher-dose pen based on the STEP UP trial
However, the evidence on how this is realized is derived mainly from limited preclinical models, and the specific pathways involved need further research and exploration
doi:10.1007/s00125-016-3874-y [DOI] [PMC free article] [PubMed] [Google Scholar] 27.Mahoney DE, Hiebert JB, Thimmesch A, et al
Over time, this toxic buildup may worsen neurological symptoms, hormonal balance, and overall immune resilience, contributing to chronic Lyme disease or post-treatment Lyme syndrome